These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Phototherapy in the treatment of cutaneous graft-versus-host disease. Our preliminary experience in resistant patients. Aubin F; Brion A; Deconinck E; Plouvier E; Hervé P; Humbert P; Cahn JY Transplantation; 1995 Jan; 59(1):151-5. PubMed ID: 7839420 [TBL] [Abstract][Full Text] [Related]
27. A pediatric case of squamous cell cancer in situ in the setting of sclerodermatous graft-versus-host disease and voriconazole treatment. Li AW; Lalor LE; Bellodi Schmidt F; Luu M Pediatr Dermatol; 2018 May; 35(3):e165-e169. PubMed ID: 29570823 [TBL] [Abstract][Full Text] [Related]
28. Dermatologic treatment of cutaneous graft versus host disease. Peñas PF; Fernández-Herrera J; García-Diez A Am J Clin Dermatol; 2004; 5(6):403-16. PubMed ID: 15663337 [TBL] [Abstract][Full Text] [Related]
30. PUVA treatment in sclerodermatoid spectrum of dermatologic diseases: our initial experience. Baum S; Pavlotsky F; Shpiro D; Trau H Isr Med Assoc J; 2004 Sep; 6(9):563-4. PubMed ID: 15373320 [No Abstract] [Full Text] [Related]
31. The role of phototherapy in cutaneous chronic graft-vs-host disease: a retrospective study and review of the literature. Ballester-Sánchez R; Navarro-Mira MÁ; de Unamuno-Bustos B; Pujol-Marco C; Sanz-Caballer J; Botella-Estrada R Actas Dermosifiliogr; 2015 Oct; 106(8):651-7. PubMed ID: 26032871 [TBL] [Abstract][Full Text] [Related]
33. "Assessment of chronic sclerodermoid Graft-versus-Host Disease patients, using 20 MHz high-frequency ultrasonography and cutometer methods". Osmola-Mańkowska A; Silny W; Dańczak-Pazdrowska A; Polańska A; Olek-Hrab K; Sadowska-Przytocka A; Żaba R; Jenerowicz D Skin Res Technol; 2013 Feb; 19(1):e417-22. PubMed ID: 22882597 [TBL] [Abstract][Full Text] [Related]
34. Long-term extracorporeal photochemotherapy in a pediatric patient with refractory sclerodermatous chronic graft-versus-host disease. Bisaccia E; Palangio M; Gonzalez J Transfus Apher Sci; 2011 Oct; 45(2):187-90. PubMed ID: 21890415 [TBL] [Abstract][Full Text] [Related]
35. Imatinib: A New Tool for the Management of Chronic Sclerodermatous Graft-Vs-Host Disease. Ferrándiz-Pulido C Actas Dermosifiliogr (Engl Ed); 2018 Apr; 109(3):200-201. PubMed ID: 29429550 [No Abstract] [Full Text] [Related]
36. [Sclerodermiform chronic graft-versus-host disease after allogenic peripheral blood stem-cell transplantation]. Neid T; Danz B; Eismann R; Bramsiepe I; Wohlrab J; Marsch WC; Fiedler E Dtsch Med Wochenschr; 2009 May; 134(21):1106-9. PubMed ID: 19437374 [TBL] [Abstract][Full Text] [Related]